Patent 7582637 was granted and assigned to SGX Pharmaceuticals on September, 2009 by the United States Patent and Trademark Office.
The present invention provides novel pyrrolo-pyridine kinase modulators and methods of using the novel pyrrolo-pyridine kinase modulators to treat diseases mediated by kinase activity.